Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Veterinary Pain Management Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Veterinary Pain Management Market Business Segmentation
2.5 Veterinary Pain Management Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Veterinary Pain Management Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Veterinary Pain Management Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Veterinary Pain Management Market has been analysed to include the below segmentation:
Drugs
• NSAIDs
• Anesthetics
• Opioids
• Other Drugs
BY PRODUCT
• Drugs
• Devices
By Application
• Osteoarthritis and Joint Pain
• Postoperative Pain
• Cancer
• Other Applications
By Animal Type
• Companion
• Livestock
Chapter 5A. Regional Segmentation
The Veterinary Pain Management Market has been analysed by studying the following regions:
North America
• Drugs
• BY PRODUCT
• By Application
• By Animal Type
Europe
• Drugs
• BY PRODUCT
• By Application
• By Animal Type
APAC
• Drugs
• BY PRODUCT
• By Application
• By Animal Type
LatAm
• Drugs
• BY PRODUCT
• By Application
• By Animal Type
MEA
• Drugs
• BY PRODUCT
• By Application
• By Animal Type
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Veterinary Pain Management Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Veterinary Pain Management Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Veterinary Pain Management Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• Assisi Animal Health
• Boehringer Ingelheim International GmbH
• CevaSanteAnimale
• Chanelle Veterinary Limited
• DechraPharmaceuticals PLC
• Elanco Animal Health Incorporated
• Norbrook
• VetoquinolSA
• Zoetis Inc
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us